Effect of olmesartan on oxidative stress in hemodialysis patients

Daisuke Kadowaki1, Makoto Anraku, Yuka Tasaki

  • 1Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Insights

Olmesartan, an angiotensin II receptor blocker, reduces oxidative stress in hemodialysis patients. This study shows olmesartan decreases oxidized albumin and albumin hydroperoxides, potentially offering benefits beyond blood pressure control.

Area of Science:

  • Nephrology
  • Cardiovascular Pharmacology
  • Oxidative Stress Research

Background:

  • Oxidative stress is a concern in hemodialysis (HD) patients.
  • The specific impact of olmesartan, an angiotensin II type 1 receptor blocker (ARB), on oxidative stress markers in HD patients requires further investigation.

Purpose of the Study:

  • To investigate the in vitro and in vivo effects of olmesartan on oxidative stress in hemodialysis patients.
  • To determine if olmesartan reduces oxidized albumin and albumin hydroperoxides.

Main Methods:

  • In vitro study: High-performance liquid chromatography (HPLC) and ferrous oxidation xylenol assay to measure oxidized albumin and albumin hydroperoxides with and without olmesartan.
  • In vivo study: Six hypertensive HD patients received 40 mg of olmesartan daily, with blood pressure and oxidized to unoxidized albumin ratio monitored over 8 weeks.

Main Results:

  • In vitro: Olmesartan significantly decreased oxidized albumin ratios and albumin hydroperoxides in a concentration-dependent manner.
  • In vivo: Olmesartan significantly reduced systolic and diastolic blood pressure within 4 weeks, with sustained reduction at 8 weeks.
  • In vivo: The ratio of oxidized to unoxidized albumin was markedly decreased after 4 weeks and maintained at 8 weeks.

Conclusions:

  • Olmesartan effectively reduces the oxidation of albumin both in vitro and in vivo.
  • The antioxidant effects of olmesartan in HD patients may provide benefits independent of its blood pressure-lowering action.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...